BNP Paribas Financial Markets Has $406,000 Position in Avanos Medical, Inc. (NYSE:AVNS)

BNP Paribas Financial Markets lowered its stake in shares of Avanos Medical, Inc. (NYSE:AVNS) by 28.8% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 16,893 shares of the company’s stock after selling 6,823 shares during the period. BNP Paribas Financial Markets’ holdings in Avanos Medical were worth $406,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in the stock. KBC Group NV raised its position in Avanos Medical by 63.0% in the third quarter. KBC Group NV now owns 2,833 shares of the company’s stock worth $68,000 after purchasing an additional 1,095 shares in the last quarter. Canada Pension Plan Investment Board acquired a new position in Avanos Medical in the second quarter worth about $70,000. XTX Topco Ltd acquired a new position in Avanos Medical in the second quarter worth about $202,000. Intech Investment Management LLC acquired a new position in Avanos Medical in the third quarter worth about $207,000. Finally, Magnetar Financial LLC acquired a new position in Avanos Medical in the second quarter worth about $248,000. Institutional investors and hedge funds own 95.17% of the company’s stock.

Avanos Medical Price Performance

Shares of Avanos Medical stock opened at $17.97 on Friday. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12. The stock has a market capitalization of $825.90 million, a price-to-earnings ratio of 52.85 and a beta of 0.95. Avanos Medical, Inc. has a 1-year low of $17.39 and a 1-year high of $25.36. The firm’s 50-day moving average price is $20.27 and its two-hundred day moving average price is $21.43.

Analyst Ratings Changes

Separately, StockNews.com lowered shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.